ReviewDrug design, development and therapy2025
Analytical Strategies for Natural Mono- and Disaccharide Isomer Differentiation: Techniques and Applications.
Review in Drug design, development and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The precise structural differentiation of natural mono- and disaccharide isomers is fundamental for understanding carbohydrate bioactivity. However, this task remains challenging due to their minimal structural variances, high polarity, and lack of chromophores. This review traces the evolution of analytical technologies designed to overcome these hurdles. Early derivatization - GC-MS methods provided the foundation for isomer separation. Modern liquid chromatography-mass spectrometry (LC-MS), particularly with advanced chiral columns, now delivers high-resolution isomer profiling. Ion mobility spectrometry (IM-MS) further distinguishes conformers by their collision cross-section (CCS) values. Recent breakthroughs in non-derivatization strategies like UHPLC, coupled with the definitive structural validation offered by 2D-NMR, have revolutionized the field. We critically evaluate these methods' detection limits and throughput for practical applications in food chemistry, clinical glycomics, and pharmaceutical analysis. Looking forward, emerging directions such as AI-assisted spectral interpretation and integrated microfluidic systems promise to propel glycan analysis toward rapid, precise, and intelligent diagnostics. This review provides a practical roadmap for selecting and advancing analytical techniques for real-world isomer characterization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.